Postoperative concurrent nedaplatin-based chemoradiotherapy improves survival in early-stage cervical cancer patients with adverse risk factors.

Mabuchi, Seiji; Morishige, Ken-ichirou; Isohashi, Fumiaki; Yoshioka, Yasuo; Takeda, Takashi; Yamamoto, Toshiya; Yoshino, Kiyoshi; Enomoto, Takayuki; Inoue, Takehiro; Kimura, Tadashi

Mabuchi, Seiji; Morishige, Ken-ichirou; Isohashi, Fumiaki; Yoshioka, Yasuo; Takeda, Takashi; Yamamoto, Toshiya; Yoshino, Kiyoshi; Enomoto, Takayuki; Inoue, Takehiro; Kimura, Tadashi.

Affiliation

Mabuchi S; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan. smabuchi@gyne.med.osaka-u.ac.jp

Gynecol Oncol ; 115(3): 482-7, 2009 Dec.

Article in En | MEDLINE | ID: mdl-19783286

Subject(s)

Antineoplastic Agents/therapeutic use; Organoplatinum Compounds/therapeutic use; Uterine Cervical Neoplasms/therapy; Adult; Antineoplastic Agents/adverse effects; Chemotherapy, Adjuvant; Female; Humans; Middle Aged; Neoplasm Staging; Organoplatinum Compounds/adverse effects; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Treatment Outcome; Uterine Cervical Neoplasms/pathology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Organoplatinum Compounds / Uterine Cervical Neoplasms / Antineoplastic Agents Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Middle aged Language: En Year: 2009 Type: Article

Fulltext

XML

PubMed Links

Search on Google